tiprankstipranks
Trending News
More News >
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
US Market

Zentalis Pharmaceuticals (ZNTL) Income Statement

Compare
340 Followers

Zentalis Pharmaceuticals Income Statement

Last quarter (Q3 2025), Zentalis Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Zentalis Pharmaceuticals's net income was $-26.69M. See Zentalis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 67.42M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 67.42M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 258.62M$ 299.51M$ 227.29M$ 216.54M$ 118.79M
Depreciation and Amortization
$ 1.29M$ 1.39M$ 1.43M$ 544.00K$ 160.00K
EBITDA
$ -186.17M$ -247.60M$ -225.86M$ -207.20M$ -118.63M
Operating Income
$ -191.19M$ -299.51M$ -227.29M$ -216.54M$ -118.79M
Other Income/Expenses
$ 25.50M$ 6.60M$ -10.29M$ 50.15M$ 683.00K
Pretax Income
$ -165.69M$ -292.91M$ -237.58M$ -166.39M$ -118.10M
Net Income
$ -165.84M$ -292.19M$ -236.81M$ -158.72M$ -117.84M
Per Share Metrics
Basic EPS
$ -2.33$ -4.47$ -4.48$ -3.72$ -2.87
Diluted EPS
$ -2.33$ -4.47$ -4.48$ -3.72$ -2.87
Weighted Average Shares Outstanding
71.08M 65.41M 52.86M 42.69M 41.04M
Weighted Average Shares Outstanding (Diluted)
71.08M 65.41M 52.86M 42.69M 41.04M
Currency in USD

Zentalis Pharmaceuticals Earnings and Revenue History